Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101805-0 DXA Calcaneus [Zscore] Bone density Zscore Bone Pt Qn     ACTIVE Bone DXA Calcaneus [Z-score] Bone density   ADD DefinitionDescription     Zscore             RAD   101805-0         Both       0 Bone DXA Z-score       N   BMD; BON; Den; DXA Z-score; Imaging; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Standard score; Z score; Z value; Z-score 2.75 2.75               {Zscore}       0
101806-8 Amyloid beta 42 peptide/Amyloid beta 40 peptide Ratio Plas Pt Qn LC/MS/MS   DEPRECATED Deprecated Amyloid beta 42 peptide/Amyloid beta 40 peptide [Ratio] in Plasma by LC/MS/MS   DEL DefinitionDescription     ratio             CHEM   101806-8   LC/MS/MS     Both       0 Deprecated AL beta42/ABeta 40 Plas LC/MS/MS-Rto       N   A Beta42/A Beta 40 Ser; Ab40 peptide; Ab42 peptide; Abeta; ABeta 40; Abeta 42; ABeta 42/40; AL beta40; AL beta42; Alzheimer disease; Alzheimer's disease; B; Beta-amyloid; Chemistry; Pept; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto 2.79 2.75       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101807-6 Malnutrition risk screen results indicator Type ^Patient Pt Nom Nutrition and dietetics   ACTIVE Malnutrition risk screen results indicator   MIN DefinitionDescription         Ã?© Skipper A, Coltman A, Tomesko J, et al. Position of the Academy of Nutrition and Dietetics: Malnutrition (Undernutrition) Screening Tools for All Adults. J Acad Nutr Diet. Apr 2020;120(4):709-713. doi:10.1016/j.jand.2019.09.011 Used with Permission         NUTRITION&DIETETICS   101807-6   Nutrition and dietetics     Observation       0 Malnut risk scn resu       N   Malnut risk scn resu; Nominal; Nutr+diet; Nutrition+Dietetics; Point in time; Random; Scn; Scr; Scrn; SDOH; Typ 2.79 2.75         Ã?© Skipper A, Coltman A, Tomesko J, et al. Position of the Academy of Nutrition and Dietetics: Malnutrition (Undernutrition) Screening Tools for All Adults. J Acad Nutr Diet. Apr 2020;120(4):709-713. doi:10.1016/j.jand.2019.09.011 Used with Permission           Release 2.79: FORMULA: Removed incorrect value from formula; 0
101808-4 Xylazine MCnc Urine Pt Qn Confirm   ACTIVE Xylazine [Mass/volume] in Urine by Confirmatory method   ADD DefinitionDescription     ng/mL             DRUG/TOX   101808-4   Confirm     Both       0 Xylazine Ur Cfm-mCnc       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Tranq; UA; UR; Urn 2.75 2.75               ng/mL       0
101809-2 Xylazine PrThr Urine Pt Ord Confirm   ACTIVE Xylazine [Presence] in Urine by Confirmatory method   ADD DefinitionDescription                   DRUG/TOX   101809-2   Confirm     Both       0 Xylazine Ur Ql Cfm       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tranq; UA; UR; Urn 2.75 2.75                       0
10181-6 Symptoms & diseases Hx Urinary tract Pt Nar     ACTIVE History of Urinary tract disorders Narrative   NAM DefinitionDescription                   H&P.HX   10181-6                 0 Hx of Urinary disorders           H+P; H+P.HX; History; Narrative; P prime; Point in time; Random; Report; Sx; Symp + dis 2.56 1.0i                     Removed "History of" from Component, changed Property from "Find" to "Hx", and removed "Reported" Method per 8/2015 Clinical LOINC Committee decision 0
101810-0 Xylazine/Creatinine MRto Urine Pt Qn Confirm   ACTIVE Xylazine/Creatinine [Mass Ratio] in Urine by Confirmatory method   ADD DefinitionDescription     ng/mg             DRUG/TOX   101810-0   Confirm     Both       0 Xylazine/Creat Ur Cfm       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Tranq; UA; UCr; UR; Urn 2.75 2.75               ng/mg       0
101811-8 2,6-dimethylaniline PrThr Urine Pt Ord Confirm   ACTIVE 2,6-dimethylaniline [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   101811-8   Confirm     Both       0 2,6-dimethylaniline Ur Ql Cfm       N   2,6-XYLIDINE; 2-Amino-m-xylene; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; II; LC/MS/MS; Ordinal; o-Xylidine; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.77 2.75                       0
101812-6 2,6-dimethylaniline/Creatinine MRto Urine Pt Qn Confirm   ACTIVE 2,6-dimethylaniline/Creatinine [Mass Ratio] in Urine by Confirmatory method   ADD DefinitionDescription     ng/mg     N/A       DRUG/TOX   101812-6   Confirm     Both       0 2,6-dimethylaniline/Creat Ur Cfm       N   2,6-XYLIDINE; 2-Amino-m-xylene; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; II; LC/MS/MS; Mass concentration ratio; Mass ratio; MCRto; o-Xylidine; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn 2.75 2.75               ng/mg       0
101813-4 2,6-dimethylaniline MCnc Urine Pt Qn Confirm   ACTIVE 2,6-dimethylaniline [Mass/volume] in Urine by Confirmatory method   ADD DefinitionDescription     ng/mL             DRUG/TOX   101813-4   Confirm     Both       0 2,6-dimethylaniline Ur Cfm-mCnc       N   2,6-XYLIDINE; 2-Amino-m-xylene; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; II; LC/MS/MS; Level; Mass concentration; o-Xylidine; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.75 2.75               ng/mL       0
101814-2 BK virus DNA ACnc CSF Pt Qn Probe.amp.tar   ACTIVE BK virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection   ADD DefinitionDescription     IU/mL             MICRO   101814-2   Probe.amp.tar     Both       0 BKV DNA CSF NAA+probe-aCnc       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; BKV; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load 2.75 2.75               [IU]/mL       0
101815-9 Cytomegalovirus DNA ACnc CSF Pt Qn Probe.amp.tar   ACTIVE Cytomegalovirus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection   ADD DefinitionDescription     IU/mL             MICRO   101815-9   Probe.amp.tar     Both       0 CMV DNA CSF NAA+probe-aCnc       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Cerebral spinal fluid; Cerebrospinal Fl; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load 2.75 2.75               [IU]/mL       0
101816-7 Cytomegalovirus DNA ACnc Urine Pt Qn Probe.amp.tar   ACTIVE Cytomegalovirus DNA [Units/volume] (viral load) in Urine by NAA with probe detection   ADD DefinitionDescription     IU/mL             MICRO   101816-7   Probe.amp.tar     Both       0 CMV DNA Ur NAA+probe-aCnc       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn; Viral load 2.75 2.75               [IU]/mL       0
101817-5 Epstein Barr virus DNA ACnc CSF Pt Qn Probe.amp.tar   ACTIVE Epstein Barr virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection   ADD DefinitionDescription     IU/mL             MICRO   101817-5   Probe.amp.tar     Both       0 EBV DNA CSF NAA+probe-aCnc       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; HHV-4; human herpesvirus 4; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load 2.75 2.75               [IU]/mL       0
101818-3 Herpes virus 6 DNA ACnc CSF Pt Qn Probe.amp.tar   ACTIVE Herpes virus 6 DNA [Units/volume] in Cerebral spinal fluid by NAA with probe detection   ADD DefinitionDescription     IU/mL             MICRO   101818-3   Probe.amp.tar     Both       0 HHV6 DNA CSF NAA+probe-aCnc       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV6; HHV-6; Human herpes virus; Human herpes virus type 6; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load 2.75 2.75               [IU]/mL       0
101819-1 Nutritional assessment for malnutrition status Find ^Patient Pt Nom     ACTIVE Nutritional assessment for malnutrition status   MIN DefinitionDescription         Ã?© 2020, Nutrition Terminology Reference Manual (eNCPT): Dietetics Language for Nutrition Care. Academy of Nutrition and Dietetics. Used with permission         CLIN.RISK   101819-1         Observation       0 Nut assess malnut status       N   CLIN; CLIN.RISK; Finding; Findings; Nominal; Nut assess malnut status; Point in time; Random; SDOH 2.79 2.75         Ã?© 2020, Nutrition Terminology Reference Manual (eNCPT): Dietetics Language for Nutrition Care. Academy of Nutrition and Dietetics. Used with permission           Release 2.79: FORMULA: Removed incorrect value from formula; Release 2.77: EXTERNAL_COPYRIGHT_LINK: Set Copyright; 0
10182-4 Travel Hx ^Patient Pt Nar     ACTIVE History of Travel Narrative   NAM DefinitionDescription                   H&P.HX   10182-4                 0 Hx of Travel           H+P; H+P.HX; History; Narrative; P prime; Point in time; Random; Report 2.56 1.0i                     Removed "History of" from Component, changed Property from "Find" to "Hx", and removed "Reported" Method per 8/2015 Clinical LOINC Committee decision 0
101820-9 Preimplantation targeted mutation analysis Find ^Embryo Pt Doc Molgen   ACTIVE Preimplantation targeted mutation analysis in Embryo by Molecular genetics method   ADD DefinitionDescription                   MOLPATH.MUT   101820-9   Molgen     Both       0 Preimplantation Mut Anl Embryo       N   Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random 2.75 2.75                       0
101822-5 Human papilloma virus cytology and high-risk genotypes panel - Cvx Pt -     ACTIVE Human papilloma virus cytology and high-risk genotypes panel - Cervix   NAM DefinitionDescription                   PANEL.MICRO   101822-5         Order       0 HPV Cyto HR genotypes Pnl Cvx       N   Cervix; Genital tract; Genital warts; HPV; HPV Cyto HR genotypes Pnl; Human papillomavirus; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random 2.76 2.75   Panel                   0
101823-3 Apolipoprotein C-III PrThr Ser/Plas Pt Doc Isoelectric focusing   ACTIVE Apolipoprotein C-III [Presence] in Serum or Plasma by Isoelectric focusing   ADD DefinitionDescription                   CHEM   101823-3   Isoelectric focusing     Both       0 Apo C-III SerPl IEF       N   3; APO; Apo C; Apo C-III; Apolipo; Apolipoprot; Apolipoprotein C3; Apolipoproteins; Chemistry; Document; IEF; Pl; Plasma; Plsm; Point in time; PR; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.75 2.75                       0
101824-1 Aspartylglucosaminidase CCnt Ser/Plas Pt Qn     ACTIVE Aspartylglucosaminidase [Enzymatic activity/mass] in Serum or Plasma   MAJ DefinitionDescription     nmol/mg             CHEM   101824-1         Both       0 AGA SerPl-cCnt       N   4-l-aspartylglycosylamine amido hydrolase; 4-l-aspartylglycosylamine amidohydrolase; AGA; Aspartylglucosaminuria; Aspartylglucosylamine deaspartylase; Aspartylglucosylaminidase; Catalytic Content; Chemistry; Glycosylasparaginase; N4-(beta-n-acetylglucosaminyl)-l-asparaginase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.76 2.75               nmol/mg       0
101825-8 Brushite crystals SatFr Urine 24H Qn     ACTIVE Brushite crystals [Saturation Fraction] in 24 hour Urine   NAM DefinitionDescription     kJ/mol             CHEM   101825-8         Both       0 Brushite Cry 24h SatFr Ur       N   1 day; 24 hours; 24HR; Chemistry; Crys; Cryst; Crystal; Percent; QNT; Quan; Quant; Quantitative; Relative Supersaturation; RS; Saturation Fraction; UA; UR; Urn 2.76 2.75               kJ/mol       0
101826-6 Sodium Urate crystals SatFr Urine 24H Qn     ACTIVE Sodium Urate crystals [Saturation Fraction] in 24 hour Urine   NAM DefinitionDescription     kJ/mol             CHEM   101826-6         Both       0 Na Urate cry 24h SatFr Ur       N   1 day; 24 hours; 24HR; Chemistry; Crys; Cryst; Crystal; Monosodium Urate; Na; Na Urate; Na Urate cry; Na+; NaU; Percent; QNT; Quan; Quant; Quantitative; Relative Supersaturation; RS; Saturation Fraction; UA; UR; Urates; Uric acid; Urn 2.76 2.75               kJ/mol       0
101827-4 Urate crystals SatFr Urine 24H Qn     ACTIVE Urate crystals [Saturation Fraction] in 24 hour Urine   NAM DefinitionDescription     kJ/mol             CHEM   101827-4         Both       0 Urate cry 24h SatFr Ur       N   1 day; 24 hours; 24HR; Chemistry; Crys; Cryst; Crystal; Percent; QNT; Quan; Quant; Quantitative; Relative Supersaturation; RS; Saturation Fraction; UA; UR; Urates; Uric acid; Urn 2.76 2.75               kJ/mol       0
101828-2 Synthetic glucocorticoid panel - Ser/Plas Pt -     ACTIVE Synthetic glucocorticoid panel - Serum or Plasma   MAJ DefinitionDescription                   PANEL.CHEM   101828-2         Order       0 Syn Glucocorticoid Pnl SerPl       N   Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Syn Glucocorticoid Pnl 2.76 2.75   Panel                   0
104,672 results found